Swine Flu News and Research

RSS
Swine Flu or influenza A (H1N1) is a new flu virus of swine origin that first caused illness in Mexico and the United States in March and April, 2009. It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread, mainly through the coughs and sneezes of people who are sick with the virus, but it may also be spread by touching infected objects and then touching your nose or mouth. Novel H1N1 infection has been reported to cause a wide range of flu-like symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, many people also have reported nausea, vomiting and/or diarrhea.
Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Scientists map key elements of immune overreaction triggered by influenza virus infection

Scientists map key elements of immune overreaction triggered by influenza virus infection

Scientists develop new anti-viral drugs that may be effective against flu virus

Scientists develop new anti-viral drugs that may be effective against flu virus

TSRI scientists describe severe immune overreaction caused by flu infections

TSRI scientists describe severe immune overreaction caused by flu infections

Swedish study confirms H1N1 vaccinations show increased risk of narcolepsy in children, adolescents

Swedish study confirms H1N1 vaccinations show increased risk of narcolepsy in children, adolescents

Three skilled nursing centers in Texas to provide free flu shots to seniors

Three skilled nursing centers in Texas to provide free flu shots to seniors

Biocryst seeks FDA NDA approval for Peramivir to treat influenza

Biocryst seeks FDA NDA approval for Peramivir to treat influenza

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

FMCNA encourages dialysis patients to get vaccinated against flu

FMCNA encourages dialysis patients to get vaccinated against flu

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

Scientists one step closer to developing universal flu vaccine

Scientists one step closer to developing universal flu vaccine

Research roundup: 'Cadillac' plan taxes; 'chronic care management' for substance abusers; long-term care services

Research roundup: 'Cadillac' plan taxes; 'chronic care management' for substance abusers; long-term care services

New technology to diagnose influenza quickly

New technology to diagnose influenza quickly

BiondVax: Priming with universal flu vaccine makes conventional bird flu vaccine effective against pandemic strains

BiondVax: Priming with universal flu vaccine makes conventional bird flu vaccine effective against pandemic strains

Best way to protect infants from influenza is to vaccinate rest of the family

Best way to protect infants from influenza is to vaccinate rest of the family

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

H7 influenza may spillover repeatedly into humans, say scientists

H7 influenza may spillover repeatedly into humans, say scientists

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NACC recommendations address established pain therapies and preview potential future advances

NACC recommendations address established pain therapies and preview potential future advances

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.